The synergistic effect of IFN-α and IFN-γ against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin

Virology Journal

Volumn 3, Issue , 2006, Pages

  Petrera, Erina ^a   Coto, Celia E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

1 CINNAMOYL 3, 11 DIHYDROXYMELIACARPIN; ALPHA2B INTERFERON; ANTIVIRUS AGENT; DRUG VEHICLE; GAMMA1B INTERFERON; MELIACINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; NONHUMAN; PLAQUE FORMING CELL; VERO CELL; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HERPESVIRUS 2, HUMAN; INTERFERON-ALPHA; INTERFERON-GAMMA; LIMONINS; MELIA AZEDARACH; VERO CELLS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2;

EID: 33746665290     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-45     Document Type: Article

References (38)

1. Waltz MA, Price RW, Hayashi K, Katz BJ, Notkins AL: Effect of immunization on acute and latent infections of vagino-uterine tissue with herpes simplex virus type 1 and 2. J Infect Dis 1977, 135:744-752.
2. Richards JT, Kern ER, Overall JC, Glasgow LA: Differences in neurovirulence among isolates of herpes simplex virus types 1 and 2 in mice using four routs of infection. J Infect Dis 1981, 144:464-471.
3. Smee DF, Martin JC, Verheyden JPH, Matthews TR: Anti-herpesvirus activity of the acyclic nuclioside 9-(1,3-dihydroxy-2-propoxymethyl) guanine. Antimicrobial Agents and Chemotherapy 1983, 23:676-682.
4. Whaley KJ, Barratt RA, Zeitlin L, Hoen TE, Cone RA: Nonoxynol-9-protects mice against vaginal transmission of genital herpes infections. J Infect Dis 1993, 168:1009-1111.
5. Andrei G, Couto AS, de Lederkremer RM, Coto CE: Purification and partial characterization of an antiviral active peptide from Melia azedarach L. Antivir Chem Chemother 1994, 5:105-110.
6. Barquero AA, Alché LE, Coto CE: Antiviral activity of meliacine on the replication of a thymidine kinase-deficient mutant of herpes simplex virus type 1 alone and in combination with acyclovir. Int J Antimicrob Agents 1997, 9:49.
7. Alché LE, Barquero AA, San Juan NA, Coto CE: An antiviral principle present in a purified fraction from Melia azedarach L leaves aqous extracts restreing herpes simplex virus type 1 propagation. Phytother Res 2002, 16:348-352.
8. Alché LE, Berra A, Beloso MJ, Coto CE: Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice. J Med Virol 2000, 61:474-80.
9. Pifarré MP, Berra A, Coto CE, Alché LE: Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice. Exp Eye Res 2002, 75:327-34.
10. Petrera E, Coto CE: Efectos de la administración in vivo del antiviral meliacina sobre el curso de la infección herpética genital murina [abstract]. Medicina 2004, 64(Suppl II):337.
11. Courrèges MC, Benencia F, Coto CE, Massouh EJ, Coulombié FC: In vitro antiphagocytic effect of Melia azedarach leaf extracts on mouse peritoneal exudate cells. J Ethnopharmacol 1994, 43:135-40.
12. Courrèges MC, Benencia F, Coulombié FC, Coto CE: In vitro and in vivo activities of Melia azedarach L. aqueous leaf extracts on murine lymphocytes. Phytomedicine 1998, 5:47-53.
13. Petrera E, Coto CE: Effect of meliacine, a plant derived antiviral, on tumor necrosis factor alpha. Fitoterapia 2003, 74:77-83.
14. Ellerman-Eriksen S: Autocrine secretion of interferon-alpha/beta and tumor necrosis factor-alpha synergistically activates macrophages after infection with herpes simples virus type 2. J Gen Virol 1993, 74:2191-2199.
15. Bohem U, Klamp T, Groot M, Howard JC: Cellular response to interferon-γ. Annu Rev Immunol 1997, 15:749-795.
16. Paludan SR, Ellermann-Eriksen S, Mogensen SC: NF-kappaB activation is responsible for the synergistic effect of herpes simplex virus type 2 infection on interferon-gamma-induced nitric oxide production. J Gen Virol 1998, 79:2785-2793.
17. Malmgaard L, Paludan SR, Mogensen SC, Ellermann-Eriksen S: Herpes simplex virus type 2 induces interleukin-12 in macrophages through a mechanism involving NF-κB. J Gen Virol 2000, 81:3011-3020.
18. Vollstedt S, Arnold S, Schwerdel C, Franchini M, Alber Gottfried, Di Santo JP, Ackermann M, Suter M: Interplay between alpha/beta and gamma interferons with B, T and natural killer cells in the defense against herpes simplex virus type 1. J of Virol 2004, 78:3846-3850.
19. Malmgaard L, Paludan SR: Interferon (IFN)-α/β, interleukin (IL)-12 and IL-18 coordinately induce production of IFN-γ during infection with herpes simplex virus type 2. J Gen Virol 2003, 84:2497-2500.
20. Sainz B Jr, Halford W: Alpha/beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J of Virol 2002, 76:11541-11550.
21. Mikloska Z, Cunningham AL: Alpha and gamma interferons inhibit herpes simplez virus type I infection and spread in epidermal cells after axonal tranmission. J Virol 2001, 75:11821-11826.
22. Alché LE, Ferek GA, Meo M, Coto CE, Meier MS: An antiviral meliacarpin from leaves of Melia azedarach L. Z Naturforsch 2003, 58:215-219.
23. Pierce AT, De Salvo J, Foster TP, Kosinski A, Séller SK, Halford WP: Beta interferon and gamma interferon synergize to block DNA and virion synthesis in herpes simplex virus-infected cells. J Gen Virol 2005, 86:2421-2432.
24. Desloges N, Rahaus M, Wolff MH: Role of protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon. J Gen Virol 2005, 86:1-6.
25. Sainz B Jr, LaMarca HL, Garry RF, Morris C: Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol J 2005, 2:14.
26. Samuel CE: Antiviral action of interferons. Clinical Microbiology Reviews 2001, 14:778-809.
27. Tan SL, Katze MG: HSV.com: maneuvering the internetworks of viral neuropathogenesis and evasion of the host defense. Proc Natl Acad Sci U S 2000, 97:5684-5686.
28. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW: Interferons regulate the phenotype of wild-type and mutant herpes simplex virus in vivo. J Exp Medicine 1999, 189:663-672.
29. Mossman KL, Sherburne R, Lavery C, Duncan J, Smiley JR: Evidence that herpes simplex virus VP16 is required for viral egress downstream of the initial envelopment event. J Virol 2000, 74:6287-99.
30. Cassady KA, Gross M, Roizman B: The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha. J Virol 1998, 72:7005-11.
31. Leib DA, Machalek MA, Williams BR, Silverman RH, Virgin HW: Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A 2000, 97:6097-101.
32. Härle P, Sainz B, Carr DJ, Halford WP: The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon alpha/beta. Virol 2002, 293:295-304.
33. Halford WP, Halford KJ, Pierce AT: Mathematical analysis demonstrates that interferons-beta and -gamma interact in a multiplicative manner to disrupt herpes simplex virus replication. J Theor Biol 2005, 234:439-54.
34. Sainz B Jr, Mossel EC, Peters CJ, Garry RF: Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virol 2004, 329:11-17.
35. Asper M, Sternsdorf T, Hass M, Drosten C, Rhode A, Schmitz H, Günther S: Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol 2004, 78:3162-3169.
36. Balish MJ, Abrams ME, Pumfery AM, Brandt CR: Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-alpha and -gamma. J Infect Dis 1992, 166:1401-3.
37. Barquero AA, Alché LE, Coto CE: Block of vesicular stomatitis virus endocytic and exocytic pathways by 1-cinnamoyl-3,11-dihydroxymeliacarpin, a tetranortriterpenoid of natural origin. J Gen Virol 2004, 85:483-93.
38. Petrera E, Joselevich M, Ghini A, Burton G, Coto CE: Antiherpes virus activities of new 6-19 carbon-bridged steroids and some synthetic precursors. Antivir Chem Chemother 2003, 14:243-8.